ClinConnect ClinConnect Logo
Search / Trial NCT06620250

A Study of the Impact of Digital Intervention on Parents/primary Caregivers' Myopia Prevention and Control Health Literacy on Preschoolers' Myopia and Physical and Mental Health

Launched by FANGBIAO TAO · Sep 30, 2024

Trial Information

Current as of August 20, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how a digital program can help parents and caregivers learn more about preventing and managing myopia (nearsightedness) in preschool children, as well as supporting their overall physical and mental health. The researchers will compare the health of children in a group using this digital intervention with a control group that does not use the program. The goal is to see if the digital tools can effectively improve the children's eyesight and general well-being.

To be eligible for this study, children should be between 3 to 6 years old and must not have any serious vision problems or other eye diseases. Parents or caregivers interested in participating will need to be comfortable using technology, volunteer for the study, and agree to fill out a questionnaire. This study is not yet recruiting participants, but once it starts, families who join can expect to engage in helpful activities that could benefit their child's eye health and overall development.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • No cognitive impairment and communication impairment
  • Volunteer and sign the informed consent
  • Fill in the questionnaire
  • Skilled in using electronic equipment
  • Exclusion Criteria:
  • Children with congenital glaucoma, cataract, strabismus and other congenital eye diseases
  • Children with a history of ocular trauma, eye surgery, or complications of myopia
  • Do not cooperate with the investigation

About Fangbiao Tao

Fangbiao Tao is a dedicated clinical trial sponsor with a focus on advancing medical research and innovation. With extensive expertise in therapeutic development, Fangbiao Tao aims to facilitate the progression of novel treatments through rigorous clinical studies that adhere to the highest ethical and scientific standards. Committed to improving patient outcomes, the organization collaborates with leading research institutions and healthcare professionals to ensure the successful execution of trials across various therapeutic areas. Through a meticulous approach to trial design and execution, Fangbiao Tao strives to contribute significantly to the evolving landscape of medical science.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported